Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOCO-CHF: Levosimendan vs placebo in advanced chronic heart failure
2017-002049-31Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic heart failure (CHF) comparing Levosimendan arm with Placebo arm (2 arms). Primary endpoint: Primary: Change in CO/PCWP at submaximal exercise. Started Jul 2017; status: completed.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2017-002049-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002049-31.